Objective To investigate the changes in cisplatin sensitivity of resistant ovarian cancer A2780 cells after inhibition of mi R- 23 a expression and explore the molecular mechanisms. Methods The drug- resistant ovarian cancer A2780 cells were exposed to cisplatin alone or in combination with antagomir- 23 a. The cell inhibition rates after the treatments were detected using MTT assay, cell cycle changes assessed with flow cytometry, and apoptotic cells observed using Hoechst33258 staining.The changes in glyc...